GATA3 and gastric cancer: In our study, which encompassed a relatively large number of gastric cancer patients (n = 402), low GATA3 expression was associated with tumors with deeper invasion (T) (P<0.001), tumors with a higher lymph node metastatic status (N) (P<0.001), cases with distant metastases (M) (P<0.001) and tumors with a later TNM stage (P<0.001).